| Rachael Masner Smith, PT | |
|
510 S 14th St, Livingston, MT 59047-3731 | |
| (406) 222-0672 | |
| Not Available |
| Full Name | Rachael Masner Smith |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 510 S 14th St, Livingston, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649602467 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Rachael Masner Smith, PT 510 S 14th St, Livingston, MT 59047-3731 Ph: (406) 222-0672 | Rachael Masner Smith, PT 510 S 14th St, Livingston, MT 59047-3731 Ph: (406) 222-0672 |
News Archive
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, found that despite death rates in the UK now being much lower than in the 1990s, the relationship between higher levels of frailty and mortality remains unchanged. Reduced mortality rates in older age appear to apply to those with little frailty, while older people with higher levels of frailty are not seeing a benefit.
A team of researchers at Heidelberg University in Germany have performed a detailed imaging analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to determine how the virus reprograms infected cells.
deCODE genetics, Inc. today announced that it has completed the previously-announced sale of its Iceland-based subsidiary deCODE genetics ehf (also known as Islensk erfdagreining) and its drug discovery and development programs to Saga Investments LLC, a private company. The sale followed approval by the U.S. Bankruptcy Court for the District of Delaware in deCODE genetics Inc.'s ongoing proceeding under Chapter 11 of the U.S. Bankruptcy Code.
Mylan Laboratories Inc. ( NYSE:MYL ) today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Azithromycin Tablets, 250 mg and 500 mg.
Behaving something like ravenous monsters, tumors need plentiful supplies of cellular building blocks such as amino acids and nucleotides in order to keep growing at a rapid pace and survive under harsh conditions. How such tumors meet these burgeoning demands has not been fully understood.
› Verified 6 days ago
Holly May, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 320 Alpenglow Ln, Livingston, MT 59047 Phone: 406-823-6414 | |
Livingston Health & Rehabilitation Center Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 510 S 14th St, Livingston, MT 59047 Phone: 406-222-0672 | |
Mark Robert Broadhead, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 510 S 14th St, Livingston, MT 59047 Phone: 406-222-0672 | |
Gary Dean Miller, P.T., CPED Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 315 S. Main St, Livingston, MT 59047 Phone: 406-222-4682 Fax: 406-222-4681 | |
Dr. Lexi Jade Klawitter, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 315 S Main St, Livingston, MT 59047 Phone: 406-222-4682 | |
Alison Shannon-lier, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 315 S Main St, Livingston, MT 59047 Phone: 406-222-4682 | |
Erika Suermann, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 510 S 14th St, Livingston, MT 59047 Phone: 406-222-0672 |